Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

N-terminus of pro-EMAP II regulates its binding with C-terminus, Arginyl-tRNA Synthetase, and Neurofilament light protein.

Xu H, Malinin NL, Awasthi N, Schwarz RE, Schwarz MA.

J Biol Chem. 2015 Feb 27. pii: jbc.M114.630533. [Epub ahead of print]

2.

Incomplete bladder duplication with multiple congenital anomalies: A rare presentation.

Awasthi NK, Goel H, Mahapatra R, Pal D.

. 2015 Jan-Mar;7(1):88-90. doi: 10.4103/0974-7796.148628.

3.

CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.

Wei ZW, Xia GK, Wu Y, Chen W, Xiang Z, Schwarz RE, Brekken RA, Awasthi N, He YL, Zhang CH.

Cancer Lett. 2015 Apr 10;359(2):335-43. doi: 10.1016/j.canlet.2015.01.033. Epub 2015 Jan 29.

PMID:
25641338
4.

Penile neurilemmoma: Utility of fine-needle aspiration cytology in diagnosis of a rare entity.

Malhotra KP, Shukla S, Gupta A, Awasthi NP, Husain N, Dhayal LR.

J Cytol. 2014 Jul;31(3):176-8. doi: 10.4103/0970-9371.145663.

5.

Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer.

Awasthi N, Hinz S, Brekken RA, Schwarz MA, Schwarz RE.

Cancer Lett. 2015 Mar 1;358(1):59-66. doi: 10.1016/j.canlet.2014.12.027. Epub 2014 Dec 16.

PMID:
25527450
6.

Cystic microfilarial infestation of the liver: a rare presentation.

Pandey A, Masood S, Awasthi NP.

Int J Infect Dis. 2015 Feb;31:15-7. doi: 10.1016/j.ijid.2014.12.008. Epub 2014 Dec 12.

7.

intraventricular tanycytic ependymoma: an uncommon fibrillary variant.

Shukla S, Malhotra KP, Awasthi NP, Husain N, Singh SK.

Neurol India. 2014 Mar-Apr;62(2):200-1. doi: 10.4103/0028-3886.132401. No abstract available.

8.

Papillary variant of medullary carcinoma thyroid.

Shukla S, Awasthi NP, Husain N.

Indian J Pathol Microbiol. 2014 Jan-Mar;57(1):151-2. doi: 10.4103/0377-4929.130933. No abstract available.

9.

Enhancement of nab-paclitaxel antitumor activity through addition of multitargeting antiangiogenic agents in experimental pancreatic cancer.

Awasthi N, Zhang C, Schwarz AM, Hinz S, Schwarz MA, Schwarz RE.

Mol Cancer Ther. 2014 May;13(5):1032-43. doi: 10.1158/1535-7163.MCT-13-0361. Epub 2014 Mar 7.

PMID:
24608575
10.

Neurosurgical procedures, spinal nerve roots - one stage removal of thoracic dumb-bell tumor: role of spinal evoked potential.

Srivastava DK, Singh D, Tiwari BC, Awasthi N, Hussain N.

Asian Cardiovasc Thorac Ann. 2014 Feb;22(2):222-5. doi: 10.1177/0218492313475642. Epub 2013 Sep 3.

PMID:
24585801
11.

Primary adenosquamous carcinoma of the prostate: a rare aggressive tumor.

Mishra S, Goel H, Awasthi N, Puri A, Mahapatra R, Pal DK.

Clin Genitourin Cancer. 2014 Feb;12(1):e29-31. doi: 10.1016/j.clgc.2013.08.006. Epub 2013 Oct 19. No abstract available.

PMID:
24145000
12.

The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer.

Zhang CΗ, Awasthi N, Schwarz MA, Schwarz RE.

Int J Oncol. 2013 Nov;43(5):1627-35. doi: 10.3892/ijo.2013.2099. Epub 2013 Sep 13.

13.

Isolated renal echinococcosis with hydatiduria in a girl.

Priyadarshi V, Singh JP, Awasthi NK, Hazra SP, Vijay MK, Pal DK.

APSP J Case Rep. 2013 Jul 15;4(2):31. eCollection 2013. No abstract available.

14.

Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer.

Awasthi N, Zhang C, Schwarz AM, Hinz S, Wang C, Williams NS, Schwarz MA, Schwarz RE.

Carcinogenesis. 2013 Oct;34(10):2361-9. doi: 10.1093/carcin/bgt227. Epub 2013 Jun 26.

15.

PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic cancer.

Ostapoff KT, Awasthi N, Cenik BK, Hinz S, Dredge K, Schwarz RE, Brekken RA.

Mol Cancer Ther. 2013 Jul;12(7):1190-201. doi: 10.1158/1535-7163.MCT-12-1123. Epub 2013 May 21.

16.

Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II.

Awasthi N, Zhang C, Hinz S, Schwarz MA, Schwarz RE.

J Exp Clin Cancer Res. 2013 Mar 6;32:12. doi: 10.1186/1756-9966-32-12.

17.

Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer.

Zhang C, Awasthi N, Schwarz MA, Hinz S, Schwarz RE.

PLoS One. 2013;8(2):e58037. doi: 10.1371/journal.pone.0058037. Epub 2013 Feb 27.

18.

Establishing a peritoneal dissemination xenograft mouse model for survival outcome assessment of experimental gastric cancer.

Zhang C, Awasthi N, Schwarz MA, Schwarz RE.

J Surg Res. 2013 Jun 15;182(2):227-34. doi: 10.1016/j.jss.2012.10.052. Epub 2012 Nov 15.

PMID:
23201270
19.

BMS-754807, a small-molecule inhibitor of insulin-like growth factor-1 receptor/insulin receptor, enhances gemcitabine response in pancreatic cancer.

Awasthi N, Zhang C, Ruan W, Schwarz MA, Schwarz RE.

Mol Cancer Ther. 2012 Dec;11(12):2644-53. doi: 10.1158/1535-7163.MCT-12-0447. Epub 2012 Oct 9.

20.

Evaluation of poly-mechanistic antiangiogenic combinations to enhance cytotoxic therapy response in pancreatic cancer.

Awasthi N, Zhang C, Ruan W, Schwarz MA, Schwarz RE.

PLoS One. 2012;7(6):e38477. doi: 10.1371/journal.pone.0038477. Epub 2012 Jun 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk